![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 6304 |
FusionGeneSummary for CD9_PPP3CA |
![]() |
Fusion gene information | Fusion gene name: CD9_PPP3CA | Fusion gene ID: 6304 | Hgene | Tgene | Gene symbol | CD9 | PPP3CA | Gene ID | 928 | 5530 |
Gene name | CD9 molecule | protein phosphatase 3 catalytic subunit alpha | |
Synonyms | BTCC-1|DRAP-27|MIC3|MRP-1|TSPAN-29|TSPAN29 | CALN|CALNA|CALNA1|CCN1|CNA1|IECEE|IECEE1|PPP2B | |
Cytomap | 12p13.31 | 4q24 | |
Type of gene | protein-coding | protein-coding | |
Description | CD9 antigen5H9 antigenBA-2/p24 antigenCD9 antigen (p24)antigen CD9cell growth-inhibiting gene 2 proteinleukocyte antigen MIC3motility related protein-1tetraspanin-29 | serine/threonine-protein phosphatase 2B catalytic subunit alpha isoformCAM-PRP catalytic subunitcalcineurin A alphacalmodulin-dependent calcineurin A subunit alpha isoformprotein phosphatase 2B, catalytic subunit, alpha isoformprotein phosphatase 3 ( | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P21926 | Q08209 | |
Ensembl transtripts involved in fusion gene | ENST00000382518, ENST00000009180, ENST00000382515, ENST00000481267, | ENST00000512215, ENST00000394854, ENST00000323055, ENST00000394853, ENST00000507176, ENST00000523694, ENST00000510292, | |
Fusion gene scores | * DoF score | 7 X 7 X 5=245 | 8 X 5 X 3=120 |
# samples | 9 | 8 | |
** MAII score | log2(9/245*10)=-1.4447848426729 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/120*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CD9 [Title/Abstract] AND PPP3CA [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CD9 | GO:0007155 | cell adhesion | 7511626 |
Hgene | CD9 | GO:0007342 | fusion of sperm to egg plasma membrane involved in single fertilization | 14575715 |
Hgene | CD9 | GO:0051271 | negative regulation of cellular component movement | 8478605 |
Hgene | CD9 | GO:0090331 | negative regulation of platelet aggregation | 18541721 |
Tgene | PPP3CA | GO:0006470 | protein dephosphorylation | 18815128|19154138 |
Tgene | PPP3CA | GO:0033173 | calcineurin-NFAT signaling cascade | 19154138|22688515 |
Tgene | PPP3CA | GO:0035690 | cellular response to drug | 11005320 |
Tgene | PPP3CA | GO:0045944 | positive regulation of transcription by RNA polymerase II | 22688515 |
Tgene | PPP3CA | GO:0051592 | response to calcium ion | 18815128 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | PRAD | TCGA-KK-A6E1-01A | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000382518 | ENST00000512215 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382518 | ENST00000394854 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382518 | ENST00000323055 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382518 | ENST00000394853 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382518 | ENST00000507176 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382518 | ENST00000523694 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382518 | ENST00000510292 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000009180 | ENST00000512215 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000009180 | ENST00000394854 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000009180 | ENST00000323055 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000009180 | ENST00000394853 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000009180 | ENST00000507176 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000009180 | ENST00000523694 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000009180 | ENST00000510292 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382515 | ENST00000512215 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382515 | ENST00000394854 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382515 | ENST00000323055 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382515 | ENST00000394853 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382515 | ENST00000507176 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382515 | ENST00000523694 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000382515 | ENST00000510292 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000481267 | ENST00000512215 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000481267 | ENST00000394854 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000481267 | ENST00000323055 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000481267 | ENST00000394853 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000481267 | ENST00000507176 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000481267 | ENST00000523694 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
5CDS-intron | ENST00000481267 | ENST00000510292 | CD9 | chr12 | 6347425 | + | PPP3CA | chr4 | 102269435 | - |
Top |
FusionProtFeatures for CD9_PPP3CA |
![]() |
Hgene | Tgene |
CD9 | PPP3CA |
Involved in platelet activation and aggregation.Regulates paranodal junction formation. Involved in cell adhesion,cell motility and tumor metastasis. Required for sperm-egg fusion.{ECO:0000269|PubMed:14575715, ECO:0000269|PubMed:7511626,ECO:0000269|PubMed:8478605}. | Calcium-dependent, calmodulin-stimulated proteinphosphatase which plays an essential role in the transduction ofintracellular Ca(2+)-mediated signals (PubMed:15671020,PubMed:18838687, PubMed:19154138, PubMed:23468591). Many of thesubstrates contain a PxIxIT motif and/or a LxVP motif(PubMed:17498738, PubMed:17502104, PubMed:23468591,PubMed:27974827, PubMed:22343722). In response to increased Ca(2+)levels, dephosphorylates and activates phosphatase SSH1 whichresults in cofilin dephosphorylation (PubMed:15671020). Inresponse to increased Ca(2+) levels following mitochondrialdepolarization, dephosphorylates DNM1L inducing DNM1Ltranslocation to the mitochondrion (PubMed:18838687).Dephosphorylates heat shock protein HSPB1 (By similarity).Dephosphorylates and activates transcription factor NFATC1(PubMed:19154138). In response to increased Ca(2+) levels,regulates NFAT-mediated transcription probably bydephosphorylating NFAT and promoting its nuclear translocation(PubMed:26248042). Dephosphorylates and inactivates transcriptionfactor ELK1 (PubMed:19154138). Dephosphorylates DARPP32(PubMed:19154138). {ECO:0000250|UniProtKB:P48452,ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:17498738,ECO:0000269|PubMed:17502104, ECO:0000269|PubMed:18838687,ECO:0000269|PubMed:19154138, ECO:0000269|PubMed:22343722,ECO:0000269|PubMed:23468591, ECO:0000269|PubMed:26248042,ECO:0000269|PubMed:27974827}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CD9_PPP3CA |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CD9_PPP3CA |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CD9 | CD82, KIT, CD63, CD81, ITGB1, IGSF8, ITGA3, CD46, ITGA5, TSPAN4, PTGFRN, CD53, CD19, CD36, SERPINH1, PRKCA, ELAVL1, LGALS3BP, ATP6V1B1, CLN8, VKORC1, ADRB2 | PPP3CA | C16orf74, PPIA, RCAN1, ADRB2, RCAN2, AKAP5, BCL2, CABIN1, MYOZ2, MYOZ1, IRF2, GRB2, AKT1, PHLPP2, PTEN, PSMA6, PDE4D, KCNIP3, TRAF3, PPP3R1, MRI1, RHOC, MAPK7, HNRNPH1, P3H1, SETSIP, MAT2B, NASP, NRD1, PDIA6, PFDN5, PPP2R2A, TNPO3, TNPO1, TSN, VBP1, XPO5, MARCH7, CEP76, TP53, VCP, JUN, FAM122A, RASSF2, PDHB, RCAN3, NFATC4, SIK3, ARFIP1, C6orf211, PSMD9, CRTC2, LBH, NCAPG, TUBA1B, DEFA1, TMEM200A, SMPD3, NFATC1, KLRG2, AATK, FGFR4, RYK, PTK7 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CD9_PPP3CA |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CD9_PPP3CA |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CD9 | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | CD9 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | CD9 | C0017636 | Glioblastoma | 1 | CTD_human |
Hgene | CD9 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
Hgene | CD9 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Hgene | CD9 | C0027658 | Neoplasms, Germ Cell and Embryonal | 1 | CTD_human |
Hgene | CD9 | C0027746 | Nerve Degeneration | 1 | CTD_human |
Hgene | CD9 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | PPP3CA | C0019202 | Hepatolenticular Degeneration | 1 | CTD_human |
Tgene | PPP3CA | C0030305 | Pancreatitis | 1 | CTD_human |
Tgene | PPP3CA | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | PPP3CA | C0039584 | Testicular Diseases | 1 | CTD_human |
Tgene | PPP3CA | C0149721 | Left Ventricular Hypertrophy | 1 | CTD_human |
Tgene | PPP3CA | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |